# Amgen Inc. (AMGN) — Q3-2014 Earnings Results

**Report date:** 2014-10-27 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2014

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 0.64%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.30 | N/A | +11.92% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their product pipeline and market position. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing investments in R&D to drive future growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock's slight increase of 0.64% reflects investor confidence, driven by strong performance in key areas. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2014_